PNP and leukemia: Originally developed for the treatment of leukemia, autoimmune disorders, and gout, PNP inhibitors, such as forodesine and ulodesine, rapidly increase serum rG and dG levels by several orders of magnitude in humans and mice and are thereby ideal tools to dissect the functions of PNP in vitro and in vivo (11–13).